Oruka Therapeutics, Inc. · NASDAQ:ORKA
Goncalves Joana sold 7,000 Oruka Therapeutics, Inc. shares (Form 4)
Traded May 15, 2026 · Filed May 15, 2026
On May 15, 2026, Goncalves Joana (Chief Medical Officer) sold 7,000 Oruka Therapeutics, Inc. shares at an average US$61.85 for US$433K under a trading plan, leaving 33,377 shares. Filed May 15, 2026 (Form 4).
- Sold
- 7,000 shares
- Price
- US$61.85 average (US$61.56 to US$63.52)
- Value
- US$433K
- Holding after
- 33,377 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Option exercise | 3,500 | US$6.84 | 36,877 | Direct |
| May 15, 2026 | Common Stock | Option exercise | 3,500 | US$7.80 | 40,377 | Direct |
| May 15, 2026 | Common Stock | Sale | 4,800 | US$61.56 | 35,577 | Direct |
| May 15, 2026 | Common Stock | Sale | 2,100 | US$62.42 | 33,477 | Direct |
| May 15, 2026 | Common Stock | Sale | 100 | US$63.52 | 33,377 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Goncalves Joana
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Goncalves Joana · Sep 15, 2026
- Form 4 · Goncalves Joana · Aug 17, 2026
- Form 4 · Goncalves Joana · Jul 15, 2026
- Form 4 · Goncalves Joana · Jun 15, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026